NCT07410559 2026-02-18Neoadjuvant Imlunestrant Plus Abemaciclib Treatment Guided by Ki67 Index After 2 Weeks for ER-Positive HER2-Negative Breast CancerFudan UniversityPhase 2 Not yet recruiting189 enrolled